Extreme reactive thrombocytosis in a healthy 6 year-old child

G de Lama Caro-Patón1, A García-Salido1,2, M I Iglesias-Bouzas1

  • 1Unidad de Cuidados Intensivos Pediátricos, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.

Anales De Pediatria
|April 15, 2020
PubMed

Insights

Extreme reactive thrombocytosis, a condition with over 1,000,000 platelets/mm³, can occur in children. This case highlights a 6-year-old requiring critical care for this rare, severe platelet elevation, often linked to infections.

Area of Science:

  • Pediatrics
  • Hematology
  • Internal Medicine

Background:

  • Thrombocytosis, elevated platelet counts, is often incidentally discovered in pediatric patients.
  • Reactive or secondary thrombocytosis is the predominant form, frequently triggered by infectious diseases.
  • Extreme thrombocytosis is defined by platelet counts exceeding 1,000,000/mm³.

Purpose of the Study:

  • To report a case of extreme reactive thrombocytosis in a previously healthy child.
  • To review the etiology, diagnostic considerations, and management of childhood thrombocytosis.
  • To discuss treatment strategies for severe cases of reactive thrombocytosis.

Main Methods:

  • Case report of a 6-year-old child admitted for diagnosis and management of extreme thrombocytosis.
  • Literature review of causes, differential diagnoses, and treatments for pediatric thrombocytosis.
  • Analysis of platelet count (peak 7,283,000/mm³) and clinical presentation.

Main Results:

  • A healthy 6-year-old presented with extreme reactive thrombocytosis (platelets 7,283,000/mm³).
  • The patient required critical care for evaluation and treatment.
  • Infectious etiology was considered the most likely cause.

Conclusions:

  • Extreme reactive thrombocytosis is a rare but significant condition in children.
  • Prompt diagnosis and critical care are essential for managing severe cases.
  • Understanding the causes and treatment options is crucial for pediatric thrombocytosis management.

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.8K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.6K
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
13.9K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
213
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.4K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.4K